Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / SPONSORED ADS
-
Total 13F shares
-
72,039,413
-
Share change
-
-4,153,474
-
Total reported value
-
$953,847,647
-
Put/Call ratio
-
2%
-
Price per share
-
$13.24
-
Number of holders
-
295
-
Value change
-
-$55,374,045
-
Number of buys
-
135
-
Number of sells
-
135
Institutional Holders of TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK) as of Q4 2024
As of 31 Dec 2024,
TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK) was held by
295 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
72,039,413 shares.
The largest 10 holders included
Capital Research Global Investors, MORGAN STANLEY, GOLDMAN SACHS GROUP INC, ARROWSTREET CAPITAL, LIMITED PARTNERSHIP, FMR LLC, FIRST TRUST ADVISORS LP, RENAISSANCE TECHNOLOGIES LLC, BRANDES INVESTMENT PARTNERS, LP, VAN ECK ASSOCIATES CORP, and BlackRock, Inc..
This page lists
296
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.